Search results
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 2 hours agoTechnical Analysis Of NVAX Stock Following the Sanofi deal, Novavax rocketed by triple digits over...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 8 hours agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
InvestorPlace· 4 days agoNovavax (NASDAQ:NVAX) stock investors are celebrating on Friday as the vaccine company’s shares hit...
3 Cheap Biotech Stocks to Buy Now: May 2024
InvestorPlace· 3 hours agoThe biotech industry is notably risky, but can produce stocks that see massive gains within a day. Well, many of these companies depend on FDA approval...
Novavax (NVAX) Set to Announce Quarterly Earnings on Friday
ETF DAILY NEWS· 6 days agoNovavax (NASDAQ:NVAX – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Friday, May 10th. Analysts expect the company to announce ...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via AOL· 4 days agoFriday, Novavax Inc (NASDAQ: NVAX) entered a co-exclusive licensing agreement with Sanofi SA...
Stocks Close Mixed As Dow Breaks Winning Streak; Meme Stock GameStop Reminiscent of 2021
Investor's Business Daily· 21 hours agoOn Wednesday eyes will be on April's Consumer Price Index data and April retail sales. Headline CPI...
Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Novavax Inc.’s record one-day gain is forcing some short sellers betting against the ...
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
Zacks· 5 days agoFree Report) came out with a quarterly loss of $1.05 per share versus the Zacks Consensus Estimate of a loss of $1.04. This quarterly report represents an earnings surprise of -0.96%. Over the ...